Ferric derisomaltose Completed Phase 4 Trials for Chronic Heart Failure (CHF) / Systolic Left Ventricular Dysfunction / Iron Deficiency (ID) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02642562Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN